Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Net Income From Continuing Operations : $-0.50 Mil (TTM As of Mar. 2008)

View and export this data going back to . Start your Free Trial

What is Nouveau Life Pharmaceuticals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Nouveau Life Pharmaceuticals's net income from continuing operations for the three months ended in Mar. 2008 was $-0.13 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2008 was $-0.50 Mil.

Nouveau Life Pharmaceuticals Net Income From Continuing Operations Historical Data

The historical data trend for Nouveau Life Pharmaceuticals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nouveau Life Pharmaceuticals Net Income From Continuing Operations Chart

Nouveau Life Pharmaceuticals Annual Data

Trend

Jun03

Jun04

Jun05

Jun06

Net Income From Continuing Operations

-0.25

-0.31

-0.40

-0.26

Nouveau Life Pharmaceuticals Quarterly Data
	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.07	-0.15	-0.12	-0.11	-0.13

Nouveau Life Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50 Mil.

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nouveau Life Pharmaceuticals Inc (OTCPK:NOUV) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501

Website

https://www.nouv.ai

Nouveau Life Pharmaceuticals Inc is a healthcare solution company that provides non-face-to-face care services. Its product portfolio includes SILBY, Tomy, Amy, Maro, and Kiromy.